Early AKI biomarkers, such as serum creatinine (sCr), serum cystatin C, plasma and urine neutrophil gelatinase associated lipocalin (NGAL), have proven to be useful in predicting AKI [63]. The gene discussed is CST3; the disease is acute kidney injury.